Latebreakers: CDC updates gonorrhea treatment guide

Article

Latebreakers: CDC updates gonorrhea treatment guide

Fluoroquinolones are no longer recommended for thetreatment of gonorrhea according to a recent update toCDC’s Sexually Transmitted Diseases Treatment Guidelines,2006. The preferred therapy is now a 125-mg dose ofceftriaxone given by intramuscular (IM) injection for uncomplicatedgonococcal infections of the cervix, urethra,and rectum. Alternative regimens available in the U.S.include single-dose ceftizoxime (Cefizox, Astellas) 500mg IM, cefoxitin 2 gm IM with 1 gm of probenecid, orcefotaxime 500 mg IM. Asingle IM dose of ceftriaxone125 mg should be used to treat uncomplicated gonococcalinfections of the pharynx, according to the newguidelines. The update can be found on-line at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.